Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Operating Expenses | 2,142 | 5,387 | 1,821 | 3,276 | 1,117 |
| Operating Income | -2,142 | -5,387 | -1,821 | -3,276 | -1,117 |
| Interest Expense | 3 | 12 | 755 | 2,366 | 792 |
| Other Income | -2 | -1,649 | -26,946 | -580 | 819 |
| Pre-tax Income | -2,147 | -7,048 | -29,522 | -6,221 | -1,090 |
| Income Tax | N/A | N/A | -2 | N/A | N/A |
| Net Income Continuous | -2,147 | -7,048 | -29,520 | -6,221 | -1,090 |
| Net Income | $-2,147 | $-7,048 | $-29,524 | $-6,221 | $-1,090 |
| EPS Basic Total Ops | -58.56 | -157.96 | -577.48 | -132.43 | -25.23 |
| EPS Basic Continuous Ops | -36.51 | -130.33 | -568.62 | -132.10 | -25.15 |
| EPS Diluted Total Ops | -58.56 | -157.96 | -577.48 | -118.02 | -32.43 |
| EPS Diluted Continuous Ops | -36.51 | -130.33 | -568.62 | -132.83 | -25.15 |
| EBITDA(a) | $-2,138 | $-5,365 | $-1,261 | $-1,193 | $-608 |